Juvenile Diabetes Research Foundation Canada
Toronto, ON M2J 5A9
President & CEO: Dave Prowten
Board Chair: Lorne Shiff
Charitable Reg. #: 11897 6604 RR0001
Grade: BThe grade is based on the charity's public reporting of the work it does and the results it achieves.
Need for Funding
Cents to The Cause
Full-time staff #117
Avg. Compensation $62,794
Top 10 Staff Salary Range
|$300k - $350k||0|
|$250k - $300k||0|
|$200k - $250k||1|
|$160k - $200k||1|
|$120k - $160k||2|
|$80k - $120k||6|
|$40k - $80k||0|
About Juvenile Diabetes Research Foundation Canada:
Founded in 1974 by parents of children with diabetes, Juvenile Diabetes Research Foundation Canada (JDRF) is the largest funder and advocate for Type 1 diabetes (T1D) research in Canada. Its focus is to find a cure for T1D and its complications. JDRF reports that 300,000 Canadians live with T1D. On average, T1D management requires 1,460 insulin shots a year. T1D often leads to life-threatening and debilitating complications which may include kidney failure, blindness, heart disease, stroke, nerve damage and amputation. The frequency of T1D among children under the age of 14 is rising, with rates doubling over the last 20 years in children under 5 years old. JDRF funds research focused on three main ideas: cure, prevention and treatment. Its main research focus includes immune therapies, regeneration, replacement, prevention, artificial pancreas, glucose control therapy and complications prevention.
In F2015, Juvenile Diabetes Research Foundation Canada awarded 121 new research grants, funding 200 global institutions and 39 research projects in Canada. The grants also funded 50 active clinical trials globally. In F2015, 350 principal investigators received funding from JDRF.
JDRF’s research surrounding an artificial pancreas is a revolutionary advance in diabetes care. In F2014, the artificial pancreas received USFDA approval. JDRF's research milestones also include beta cell encapsulation (implanting stem cells to "heal" T1D). In F2015, the first cohort of Canadian participants began testing the safety of the encapsulation product. In F2016, JDRF plans to test the tolerability and efficacy of the product, which could allow those with T1D to live free of insulin injections. Finally, JDRF’s stem cell research focuses on converting stem cells into insulin-producing pancreatic cells. This can rapidly reverse diabetes following a transplant.
This is the most recent output data available. As of the date this report was updated, JDRF had yet to publish its annual report for F2016.
Juvenile Diabetes Research Foundation Canada is a Major 100 charity with donations of $20.1m in F2016. Administrative costs were 22% of revenues and fundraising costs were 47% of donations. For every $1 donated, 32 cents went to the cause. This falls outside of Charity Intelligence’s range for reasonable overhead spending.
The Foundation has funding reserves of $7.3m, of which $86k is donor-endowed. Excluding donor-endowed funds, the Foundation has enough funds on hand to cover just over 11 months of grants and programs.
This charity report is an update that is currently being reviewed by Juvenile Diabetes Research Foundation Canada. Changes and edits may be forthcoming.
Updated on July 24, 2017 by Juliana Badovinac.
Financial RatiosFiscal year ending December
|Administrative costs as % of revenues||21.5%||20.9%||18.7%|
|Fundraising costs as % of donations||46.8%||48.9%||47.1%|
|Program cost coverage (%)||93.8%||94.7%||105.7%|
Summary Financial StatementsAll figures in $000s
|Cash flow from operations||(1,390)||(2,565)||(2,160)|